Pattern of Drug Sales at Community Pharmacies in Edo State as Evidence of Self-medication during the COVID-19 Pandemic: Implications for Policy Implementation
DOI:
https://doi.org/10.60787/tnhj.v20i4.499Keywords:
Self-medication, COVID-19, community pharmacists, Benin CityAbstract
Background: Inappropriate self-medication, recognized as one of the indirect health effects of the COVID-19 pandemic, is especially worrisome because of reported toxicity and unproven efficacy of various drug combinations touted as cures for the disease. Little scientific documentation exists on the range of drugs being self-medicated during the pandemic in Nigeria. This study assessed the pattern of drug sales at community pharmacies during the COVID-19 pandemic to ascertain the drugs commonly used for self-medication.
Methods: A descriptive cross-sectional study was conducted across community pharmacies in Benin City, Edo state in June 2020 to assess the pattern of sales of drugs. Data was collected using a self-administered questionnaire and a record review of medication sales carried out to compare sales in the 1st and 2nd quarters of 2020. Data were analyzed using IBM-SPSS version 25.0.
Results: Sixty-two community pharmacies were assessed. Of these, record review showed an increase in sales in the 2nd Quarter, compared to the 1st quarter, of Hydroxychloroquine 62 (100.0%), Chloroquine 51 (82.3%), vitamin C 62 (100.0%) and immune boosters 61 (98.4%). Forty-one (66.1%) community pharmacies reported an increase in sales of Azithromycin and Zinc respectively and 27 (43.5%) reported an increase in the sales of Artemisinin-based combination therapy. Prescription sheets were not mandatory for the sales of these medications in any of the pharmacies.
Conclusion: There was an increase in sales of antimalaria, antibiotics, and multivitamins reported to be useful in the management of COVID-19 without prescription. Implementation of drug policies is necessary to guarantee public safety.
Downloads
References
El Bcheraoui, C., Weishaar, H., Pozo-Martin, F. et al. Assessing COVID-19 through the lens of health systems’ preparedness: time for a change. Global Health 2020; 16: 112. https://doi.org/10.1186/s12992-020-00645-5
World Health Organisation. Weekly epidemiological update - 17 November 2020 Available at https://www.who.int/publications/m/item/weekly-epidemiological-update---17-november-2020 (Accessed on November 20, 2020)
Elston JWT, Cartwright C, Ndumbi P, Wright J. The health impact of the 2014-15 Ebola outbreak. Public Health 2017;143: 60-70
Migliori GB, Thong PM, Akkerman O, Alffenaar J, Álvarez-Navascués F, Assao-Neino MM et al. Worldwide effects of coronavirus disease pandemic on tuberculosis services, January-April 2020. Emerg Infect Dis 2020; 26(11): 2709-2712
Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y et al. Early estimates of the indirect effect of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020;8: e901-e908
Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N et al. The psychological impact of quarantine and how to reduce it: a rapid review of the evidence. Lancet 2020; 395: 912-920
Zaami S, Marinelli E, Vari MR. New trends of substance abuse during COVID-19 pandemic: an international perspective. Front Psychiatry 2020; 11: 700. doi:10.1097/ADM.000000000000685
World Health Organisation. Guidelines for the regulatory assessment of medical products for use in self-medication. Geneva: World Health Organisation; 2000
Eticha T, Mesfin K. Self-medication practices in Mekelle, Ethiopia. PLoS One 2014; 9(5): e97464
Alghanim S.A. Self-medication practice among patients in a public health care system. Eastern Mediterrenean Health Journal. 2011;17(5): 409 – 416
Limaye D, Limaye V.., Krause G., Fortwengel G. A systematic review of the literature to assess self-medication practices. Ann Med Health Sci Res. 2017; 7: 1-15.
Esan D.T., Fasoro A.A., Odesanya O.E., Esan T.O., Ojo E.F., Faeji C.O. Assessment of self-medication practices and its associated factors among undergraduates of a private university in Nigeria. J Environ Public Health. 2018; 2018: 5439079 Available from: https://doi.org/10.1155/2018/5439079
Malik M, Tahir MJ, Jabbar R, Ahmed A, Hussain R. Self-medication during COVID-19 pandemic: challenges and opportunities. Drug Ther Perspect 2020; 36: 565-567
Mudenda S, Witika BA, Sadiq MJ, Banda M, Mfune RL, Daka V et al. Self-medication and its consequences during and after the coronavirus disease 2019 (COVID-19) pandemic: a global health problem. Europ J Environ Public Health 2020: 5(1): em0066
Onchonga D, Omwoyo J, Nyamamba D. Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya. Saudi Pharmaceutial Journal 2020; 28(10): 1149-1154
Islam MS, Sarkar T, Khan SH, Mostofa Kamal AH, Hasan SMM, Kabir A. COVID-19 related infodemic and its impact on public health: a global social media analysis. AJTMH 2020; 103(4): 1621-1629
Mallhi TH, Khan YH, Alotaibi NH, Alzarea AI, Alanazi AS, Qasim S, Iqbal MS, Tanveer N. Drug repurposing for COVID-19: a potential threat of self-medication and controlling measures. Postgrad Med J. 2020 Aug 26:postgradmedj-2020-138447. doi: 10.1136/postgradmedj-2020-138447. Epub ahead of print. PMID: 32848085; PMCID: PMC7448118.
World Health Organization. Coronavirus disease (COVID-19) advice for the public: mythbusters. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters. Accessed 6 Sep 2020
Self WH, Semler MW, Leither LM, Casey JD, Angus DC, Brower RG et al. Effects of hydroxychloroquine on clinical status at 14 days in hospitalized patients with COVID-19: a randomized clinical trial. JAMA 2020; 324(21): 2165-2176.
Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR et al. Effects of Hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 2020; 383(21): 2030-2040
Cavalcanti AB, Zampieri F, Rosa RG, Azevedo LCP, Veiga VC, Avezum A et al. Hydroxychloroquine with or without Azithromycin in mild to moderate Covid-19. N Engl J Med 2020; 383(21): 2041-2052
Rajasingham R, Bangdiwala AS, Nicol MR, Skipper CP, Pastick KA, Axelrod ML et al. Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial. Clin Infect Dis 2020; ciaa1571. https://doi.org/10.1093/cid/ciaa1571
Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 2020; 383: 517-525
Herb F Sewell, Raymond M Agius, Denise Kendrick, Marcia Stewart. Covid-19 vaccines: delivering protective immunity. BMJ 2020; 371:m4838.
Sadio AJ, Gbeasor-Komlanvi FA, Konu RY, Bakoubayi AW, Tchankoni MK, Bitty-Anderson A et al. Assessment of self-medication practices in the context of COVID-19 outbreak in Togo. Research Square preprint 2020
Wegbom AI, Edet CK, Raimi O, Fagbamigbe AF, Kiri VA. Self-medication practices and associated factors in the prevention and/or treatment of COVID-19 virus: a population-based survey in Nigeria. Research square preprint 2020. https://doi.org/10.21203/rs.3.rs-91101/v1
Nasir M, Chowdhury AS, Zahan T. Self-medication during the COVID-19 outbreak: a cross-sectional online survey in Dhaka city. Int J of Basic Clin Pharmacol 2020; 9(9): 1325-1330
Obaseki DE, Akoria O, Ogboghodo EO, Obarisiagbon OE, Mokogwu N, Omo-Ikirodah OT et al . Mainstreaming the private health sector in the response to COVID-19: facility readiness assessment for screening services in Edo state, Nigeria. PAMJ 2020 35: 93. doi: 10.11604/pamj.supp.2020.35.2.24468.
Edo State Government. About Edo State. Accessed 24 April 2020.
Oparah AC, Arigbe-Osula EM. Evaluation of community pharmacists’ involvement in primary health care. Trop J Pharm Res 2002; 1 (2): 67-74
Obaseki DE, Akoria OA, Mokogwu N, Omuemu CE, Okwara BU, Ogboghodo EO, 2020. Staff risks stratification in preparation for COVID-19 in a tertiary healthcare facility in Nigeria. PAMJ 35: 124. Doi:10.11604/pamj.supp.2020.35.2.25095
Nigeria Centre for Disease Control (NCDC). COVID 19 progression. Available at https://covid19.ncdc.gov.ng/progression/. Accessed 26th August, 2020
Lane JCE, Weaver J, Kostka K, Duarte-Salles T, Abrahao MT, Alghoul H et al. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. Lancet Rheumatol 2020; 2(11): e698-e711
Mehta B, Salmon J, Ibrahim S. Potential shortages of hydroxychloroquine for patients with lupus during the coronavirus disease 2019 pandemic. JAMA Health Forum. 2020. https://doi.org/10.1001/jamahealthforum.2020.0438
Hedima EW, Adeyemi MS, Ikunaiye NY. Community Pharmacists: On the frontline of health service against COVID-19 in LMICs. Res Social and Adm Pharm. 2021; 17(1): 1964-1966. doi:10.1016/j.sapharm.2020.04.013
Ahmad A, Alkharfy KM, Alrabiah Z, Alhossan A. Saudi Arabia, pharmacists and COVID-19 pandemic. J Pharm Policy Pract 2020; 13: 41
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 The Nigerian Health Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
